Podimetrics – Revolutionize diabetic foot care for your patients Skip to main content Skip to footer Download our new eBook today! Breaking Barriers: Combatting Diabetic Amputations in Communities of ColorPeople of Color bear the heaviest
Revolutionize diabetic foot care for your patients Read More »
HOUSTON, TX – February 5, 2024 – Procyrion™, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today the completion of a $57.7 million Series E funding round, including the conversion of $10.0 million of interim financing. These funds will be used to support the ongoing DRAIN-HF
Procyrion Closes $57.7 Million in Series E Financing Read More »
February 2, 2024 – Woburn, MA Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings, today announced that the company will be participating in the 2024 International Master Course on Aging Science (IMCAS) World Congress, taking place February 1 – 3, 2024, in Paris. Chief Executive Officer and President, Jon
Eirion Therapeutics to Present at the 2024 IMCAS World Congress Read More »
HOUSTON, TX – NOVEMBER 30, 2023 – Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced the enrollment of the first patients in the company’s IDE pivotal trial. The DRAIN-HF (Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure) study will evaluate the Aortix™ percutaneous
San Diego, CA – November 27th, 2023 – Mindera Health™, a leading provider of precision medicine solutions for psoriasis, today announced that it will be relocating its commercial activities to a new office building at 1221 Liberty Way, Vista, CA 92081 on December 1st, 2023. The new facility is over 19,000 square feet and features
Mindera Health ™ Announces Commercial Relocation Read More »
Company secures funding to fuel expansion of its Thoraguard® System; adds veteran medtech leader Timothy Still to Board of Directors Centese, Inc., a leader in digital surgery technology, announces the successful closing of its $15M Series B funding round. The round, led by Medical Technology Venture Partners with participation from new and existing investors, will
Centese, Inc. Secures Series B Funding and Strengthens Board With New Director – Read More »
OAKLAND, Calif. and NEW YORK, NY, Nov.15, 2023 OrbiMed, a leading healthcare investment firm and Koya Medical, a healthcare company with a mission to transform venous and lymphatic treatments through novel, people-centric solutions, today announced the closing of a financing for up to $30 million. The capital will support the company’s strategic expansion and continued
Koya Medical Raises New Capital with OrbiMed to Support Growth Read More »
San Diego, CA, Nov. 06, 2023 (GLOBE NEWSWIRE) — Mindera Health today announces the signing a commercial agreement with Occum Health, LLC, a healthcare solutions company that is focused on delivering savings and improved benefits to self-insured employers. Through this agreement, Mindera’s proprietary psoriasis biologic prediction test, Mind.Px, is available to Occum Health’s more than
San Diego, CA, Oct 23, 2023 (GLOBE NEWSWIRE) — Mindera Health™, the developer of Mind.Px, the first realization of precision medicine in psoriasis, announces that it has signed a provider contract with Contigo Health ConfigureNetTM provider network. This commercial agreement will make Mindera’s psoriasis biologic prediction test, Mind.Px, available to clients and their health plan members
Mindera Health, a precision medicine company developing personalized tools to optimize patient outcomes, today announced that additional patent protection has been issued in Australia for the core technology behind the dermal biomarker patch. Australian patent number 2020239750 was issued August 3, 2023 and covers devices that can extract dermal biomarkers in situ. The inventors